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Abstract
Enterobacter aerogenes (E. aerogenes) has been commonly described as a versatile opportunistic pathogen in 
hospital infections. The aim of the present work was to evaluate the impact of biofield treatment on E. aerogenes for 
its phenotypic and genotypic characteristics. E. aerogenes bearing ATCC 13048 (American Type Culture Collection) 
was procured from Bangalore Genei, in sealed pack and divided into control and treated groups. Treated group 
was subjected to Mr. Trivedi’s biofield treatment and analyzed for antimicrobial susceptibility, minimum inhibitory 
concentration (MIC), biochemical reactions, and biotype using automated MicroScan Walk-Away® system. In addition, 
treated group of E. aerogenes was evaluated for DNA polymorphism by Random Amplified Polymorphic DNA (RAPD) 
and 16S rDNA sequencing to establish the phylogenetic relationship of E. aerogenes with different closely related 
bacterial species. Antimicrobial susceptibility results showed an alteration of 14.28% among twenty-eight tested 
antimicrobials. Similarly, 15.65% tested antimicrobials showed an alteration in MIC values. Chloramphenicol showed 
improved sensitivity i.e. resistant to susceptible after biofield treatment, with the support of decreased MIC by two 
folds (i.e. >16 to ≤8 µg/mL). Norfloxacin also showed decrease MIC by two folds (i.e. 8 to ≤4 µg/mL) as compared 
to control. Biofield treatment showed an impact on biochemical reactions (9.09%) followed by a change in biotype 
number (7770 5272) in treated group with respect to control (7770 5372). Using RAPD analysis, sample showed an 
average range of 4 to 42% of polymorphism, while 16S rDNA study showed that treated sample was detected as 
Kluyvera cryocrescens (GenBank Accession Number: AM184245) with 97% identity of gene sequencing data, which 
was nearest homolog species to Enterobacter aerogenes strain: C1111 (Accession No. AB244467). These results 
suggest that Mr. Trivedi’s unique biofield treatment can alter the antimicrobial sensitivity pattern, thus it can be used as 
alternate energy medicine in future.
Keywords: Enterobacter aerogenes, Biofield treatment; Phenotyping, 
Polymorphism; RAPD; 16S rDNA analysis
Introduction
Enterobacter aerogenes (E. aerogenes) is a common organism of 
most of the hospital-acquired infections. Adaptive capability of E. 
aerogenes is remarkable and can easily acquire resistance to against 
β-lactam antibiotics [1]. During last five years, it has shown that E. 
aerogenes isolates are having natural resistance against aminopenicillins, 
and express an extended-spectrum β-lactamase (ESBL), which results 
resistance to β-lactam antibiotics [2]. However, E. aerogenes exhibits 
acquired resistance against different categories of antimicrobial agents. 
General resistance mechanisms exhibited by E. aerogenes involves 
membrane permeability, p-glycoprotein efflux pump, and enzyme 
degradation against carbapenems, fluoroquinolones, quinolones, 
tetracycline, and chloramphenicol [3]. Currently, colistin, and 
polymyxin antibiotic have been preferred as alternative drugs against 
Gram-negative pathogens, due to the extended resistance of Gram-
negative bacteria against almost all antibiotics [4]. Recently, colistin in 
antibiotic therapy shows serious toxicity and associated adverse effects 
like neurotoxicity and nephrotoxicity [5]. Because of all the associated 
side effects and failure of drug treatment therapy, alternate treatment 
approach is required. Recently, an alternate treatment is known as 
biofield energy and is reported that inhibits the growth of bacterial 
cultures [6].
Biofield is the name given to the electromagnetic field that 
permeates and surrounds living organisms [7]. It is referred as 
biologically produced electromagnetic and subtle energy field that 
provides regulatory and communication functions within the human 
organism. Various internal physiological processes such as blood flow, 
brain, heart function, etc. that generate biofield. Biomagnetic fields 
around the human body can be measured using different techniques 
[8]. Researchers have attempted different biological studies and effects 
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of biofield on various biomolecules such as proteins, antibiotics [9], 
and conformational change in DNA [10], bacterial cultures [11] etc. 
Thus, it can be concluded that human can to harness the energy from 
environment or universe and can transmit into any living or nonliving 
object(s) around the Universe. The objects always receive the energy 
and responding to useful way that is called biofield energy. Mr. 
Trivedi’s unique biofield treatment has been well known and studied 
in the field of material science [12-14], agricultural science [15-17], 
and biotechnology [18]. Mr. Trivedi’s unique biofield treatment is 
also known as The Trivedi Effect®, which was also reported in altering 
the susceptibility of antimicrobials against pathogenic and multidrug 
resistant microbes [19-21].
After consideration of the clinical significance of E. aerogenes and 
significant impact of Mr. Trivedi’s biofield treatment on microbes, 
authors evaluated the effect of biofield treatment on E. aerogenes 
followed by genotyping of treated organism. Genotyping was 
performed using strain differentiation and distinctive polymorphism 
using polymerase chain reaction (PCR) technique of random amplified 
polymorphic DNA analysis (RAPD) and 16S rDNA sequencing.
Materials and Methods
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Enterobacter aerogenes ATCC 13048 [American Type Culture 
Collection] was procured from Bangalore Genei, in sealed pack, and 
stored as per the recommended storage conditions for further use. 
The anti-microbial susceptibility, biochemical reactions, and biotype 
number were evaluated on MicroScan Walk-Away® (Dade Behring Inc., 
West Sacramento, CA) using Negative Breakpoint Combo 30 (NBPC 
30) panel. DNA fingerprinting (RAPD) and the 16S rDNA sequencing 
studies were carried out using Ultrapure Genomic DNA Prep Kit; 
Cat KT 83 (Bangalore Genei, India). All the tested antimicrobials, 
biochemicals and other reagents were procured from Sigma-Aldrich, 
India.
Study design and biofield treatment
E. aerogenes strain was divided into two groups i.e. control and 
treatment. The treatment group was in sealed pack and handed over 
to Mr. Trivedi for biofield treatment under laboratory conditions. Mr. 
Trivedi provided the treatment through his energy transmission process 
to the treated group without touching the sample. After treatment, 
control and treated groups were assessed on day 10 for antimicrobial 
susceptibility, minimum inhibitory concentration (MIC), biochemical 
reactions, biotype, and genotyping using RAPD and 16S rDNA analysis. 
The results of treated samples were compared with respect to control. 
Investigation of antimicrobial susceptibility assay
Investigation of antimicrobial susceptibility of E. aerogenes was 
carried out with the help of automated instrument, MicroScan Walk-
Away® using Negative Breakpoint Combo 30 (NBPC30) panel as per 
the manufacturer’s instructions. The panel was allowed to equilibrate 
to room temperature prior to rehydration. All opened panel were used 
on the same day. The tests were carried out on MicroScan, which were 
miniaturized of the broth dilution susceptibility test that has been 
dehydrated. Briefly, 0.1 mL (100 μL) of the standardized suspension of 
E. aerogenes was pipetted into 25 mL of inoculum water using pluronic 
and inverted 8-10 times and inoculated, rehydrated, and then subjected 
to incubation for 16 hours at 35°C. Rehydration and inoculation was 
performed using the RENOK® system with inoculators-D (B1013-4). 
The detailed experimental procedures and conditions were followed 
as per the manufacturer’s instructions. Briefly, after inoculation and 
rehydration with a standardized suspension of E. aerogenes, it was 
incubated at 35°C for 16 hours. MIC and a qualitative susceptibility 
like susceptible (S), intermediate (I), inducible β-lactamases (IB), and 
resistant (R) were determined by observing the lowest antimicrobial 
concentration showing growth inhibition [22]. 
Biochemical studies: The biochemical reactions of E. aerogenes 
were determined by MicroScan Walk-Away® system, it interprets 
the microbe biochemical results with the use of a photometric or 
fluorogenic reader. On the basis of nature of bacilli (Gram-negative or 
Gram-positive), it generates computerized reports using conventional 
panels, which utilizes the photometric reader and provide identification 
results. Before commencing the experiment, the NBPC 30 panel was 
first incubated and read on the MicroScan Walkaway system. After 
completion of reading on the Walkaway system, the NBPC 30 panel was 
removed from system and read on the Biomic system within 1 hour. 
MicroScan Walk-Away instrument consist of a database associated 
with collective information, which was required to identify the group, 
genera, or species of the family. Detailed experimental procedure was 
followed as per manufacturer-recommended instructions [22].
Biotype number: The biotype number of E. aerogenes was 
determined by MicroScan Walk-Away® processed panel data utilizing 
data of biochemical reactions. Similar experimental procedure 
was followed for identification of biotype number as described in 
biochemical reaction study, and as per manufacturer-recommended 
instructions [22].
Random Amplified Polymorphic DNA (RAPD) analysis
Three series of inoculums (one for control and other two for 
treatment named as treatment A and B) were prepared from E. aerogenes 
sample. Two inoculums (treatment samples A and B) were subjected 
to Mr. Trivedi’s biofield treatment. Whilst handing over treated groups 
to Mr. Trivedi for biofield treatment, optimum precautions were taken 
to avoid the contamination. After that, the treated samples (A and B) 
were sub-cultured by taking 1% inoculum and inoculated to fresh 5 mL 
medium and labeled as treatment A-1 and treatment B-1 respectively. 
Control and treated samples were incubated at 37°C with 160 rpm for 
18 h. Subsequently, the cultures were spun down, and genomic DNA 
was isolated for control and treated samples using Genomic DNA Prep 
Kit (Bangalore Genei, India). Designed primers were initially screened 
for their sharpness, further primers that have the basic of sharpness, 
clarity of the profile and the existence of polymorphisms were chosen 
for further study. RAPD was performed with all samples of E. aerogenes 
using five RAPD primers, which were labelled as RBA8A, RBA13A, 
RBA20A, RBA10A and RBA15A. The PCR mixture contained 2.5 μL 
each of buffer, 4.0 mM each of dNTP, 2.5 μM each of primer, 5.0 μL each 
of genomic DNA, 2U each of Taq polymerase, 1.5 μL of MgCl2 and 9.5 
μL of nuclease-free water in a total of 25 μL mixture. PCR amplification 
protocol followed with initial denaturation at 94ºC for 7 min, followed 
by 8 cycles of denaturation at 94ºC for 1 min, annealing at 35ºC for 1 
min, and extension at 72ºC for 2 min; and 35 cycle of denaturation at 
94ºC for 1 min, annealing at 38ºC for 1 min, and extension at 72ºC 
for 1.5 min; and the final extension at 72ºC for 7 min. Amplified PCR 
products (12 μL) from all samples (control and treated) were separated 
on 1.5% agarose gels at 75 volts, stained with ethidium bromide and 
visualized under UV illumination [23]. 
The percentage of polymorphism was calculated using following 
equation- 
Percent polymorphism = A/B×100; 
Where, A = number of polymorphic bands in treated sample; and B 
= number of polymorphic bands in control.
Amplification and gene sequencing of 16S rDNA
Genomic DNA was isolated and purified from a treated group 
of E. aerogenes cells by using genomic purification Kit, as per the 
manufacturer’s instructions. The PCR product was bi-directionally 
sequenced using the forward, reverse, and an internal primer. DNA 16S 
region amplification was performed using the primer set 16S forward and 
reverse primer [24]. 16S rDNA gene (~1.5 kb) was amplified by universal 
primers; forward primer (5ˊ-AGAGTTTGATCCTGGCTCAG-3ˊ) 
and reverse primer (3ˊ-ACGGTCATACCTTGTTACGACTT-5ˊ). 
Amplification was carried out in a Rapid Cycler thermocontroller, with 
initial denaturation, annealing and extension temperature. Following 
amplification products were analyzed by gel electrophoresis at 100 V 
(in 1.0% agarose gel, 0.2 µg of ethidium bromide mL-1) in tris-acetate 
buffer (TAE), and visualized under UV light in a gel documentation 
unit (BioRad Laboratories, USA). The amplified fragment of PCR was 
purified from the agarose gel by DNA Gel Extraction Kit. Sequencing of 
amplified product was carried out on a commercial basis from Bangalore 
Genei, India. The obtained 16S rDNA sequences data were aligned 
and compared with the sequences, available in GenBank database 
of National Center for Biotechnology Information (NCBI) using 
the algorithm BLASTn program. The multiple sequence alignment/
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phylogenetic tree were constructed using MEGA 3.1 software using 
neighbor-joining method [25]. 
Results and Discussion
Assessment of antimicrobial susceptibility 
The effect of biofield treatment on E. aerogenes with respect to 
antimicrobials susceptibility pattern and MIC are summarized in Tables 
1 and 2, respectively. The data were analyzed and compared with respect 
to control. The treated cells of E. aerogenes showed 14.28% alteration out 
of twenty-eight tested antimicrobials as compared to control. Results 
showed altered antibiogram of cefotaxime, cefotetan, chloramphenicol, 
and piperacillin as compared to control. Cefotaxime was converted from 
inducible β-lactamases to intermediate, while cefotetan changed from 
inducible β-lactamases to resistant. Chloramphenicol resistance profile 
was improved from resistant to susceptible as compared to control. 
Piperacillin sensitivity was also altered from inducible β-lactamases 
to intermediate. Rest of the tested antimicrobials did not show any 
alteration in sensitivity with respect to control.
Similarly, sensitivity results of tested antimicrobials are well 
supported with MIC results (Table 2). Cefotaxime showed four folds 
alteration in MIC value (32 µg/mL) while cefotetan showed two folds 
change in MIC value (>32 µg/mL) with respect to control. Improved 
sensitivity of chloramphenicol also showed decreased MIC value by two 
folds (i.e. >16 to ≤8 µg/mL) as compared to control. Norfloxacin also a 
showed decrease in MIC value by two folds after biofield treatment with 
S. No. Antimicrobial Control Treated
1 Amikacin S S
2 Amoxicillin/k-clavulanate R R
3 Ampicillin/sulbactam I I
4 Ampicillin R R
5 Aztreonam IB IB
6 Cefazolin R R
7 Cefepime S S
8 Cefotaxime IB I
9 Cefotetan IB R
10 Cefoxitin R R
11 Ceftazidime IB IB
12 Ceftriaxone IB IB
13 Cefuroxime IB IB
14 Cephalothin R R
15 Chloramphenicol R S
16 Ciprofloxacin S S
17 Gatifloxacin S S
18 Gentamicin S S
19 Imipenem S S
20 Levofloxacin S S
21 Meropenem S S
22 Moxifloxacin S S
23 Piperacillin/tazobactam IB IB
24 Piperacillin IB I
25 Tetracycline S S
26 Ticarcillin/k-clavulanate IB IB
27 Tobramycin S S
28 Trimethoprim/sulfamethoxazole S S
R: Resistant; I: Intermediate; S: Susceptible; ‘-‘: IB: Inducible β-lactamases; deleted
Table 1: Effect of biofield treatment on multidrug resistant lab isolates of 
Enterobacter aerogenes to antimicrobial susceptibility.
respect to control (i.e. 8 to ≤4 µg/mL). However, piperacillin showed 
four folds change in MIC value (i.e. ≤16 to 64 µg/mL) as compared 
to control. Overall, 15.65% tested antimicrobials showed altered MIC 
values with respect to control. The rest of the tested antimicrobials did 
not show any alteration in MIC values with respect to control data. 
According to National health statistics reports of National Center 
for Health Statistics in the Unites States, 2002-2012, biofield treatment as 
an alternative energy medicine was well reported and practiced among 
adults [26]. The current experiment was designed to demonstrate 
the impact of biofield treatment on E. aerogenes for its susceptibility 
pattern, biochemical reaction, and biotype number. Further, molecular 
methods were performed to study the genetic alterations and similarities 
using RAPD and 16S rDNA sequencing methods. Increased emergence 
of resistant E. aerogenes is a global health problem, as an emerging 
Gram-negative pathogen in Enterobacteriaceae family, associated with 
severe hospital acquired infections. E. aerogenes isolates have a broad 
ability to develop antimicrobial resistance [27]. Results showed, biofield 
treatment has induced change in susceptibility pattern of antimicrobials 
such as cefotaxime, cefotetan, chloramphenicol, and piperacillin as 
compared to control. Chloramphenicol showed improved sensitivity 
after biofield treatment from resistant to susceptible. Chloramphenicol 
exhibited natural resistance against E. aerogenes, and it was mediated 
S. No. Antimicrobial Control Treated
1 Amikacin ≤16 ≤16
2 Amoxicillin/K-clavulanate >16/8 >16/8
3 Ampicillin/sulbactam 16/8 16/8
4 Ampicillin >16 >16
5 Aztreonam ≤8 ≤8
6 Cefazolin >16 >16
7 Cefepime ≤8 ≤8
8 Cefotaxime ≤8 32
9 Cefotetan ≤16 >32
10 Cefoxitin >16 >16
11 Ceftazidime ≤8 ≤8
12 Ceftriaxone ≤8 ≤8
13 Cefuroxime ≤4 ≤4
14 Cephalothin >16 >16
15 Chloramphenicol >16 ≤8
16 Ciprofloxacin ≤1 ≤1
17 ESBL-a Scrn ≤4 ≤4
18 ESBL-b Scrn ≤1 ≤1
19 Gatifloxacin ≤2 ≤2
20 Gentamicin ≤4 ≤4
21 Imipenem ≤4 ≤4
22 Levofloxacin ≤2 ≤2
23 Meropenem ≤4 ≤4
24 Moxifloxacin ≤2 ≤2
25 Nitrofurantoin 64 64
26 Norfloxacin 8 ≤4
27 Piperacillin/tazobactam ≤16 ≤16
28 Piperacillin ≤16 64
29 Tetracycline ≤4 ≤4
30 Ticarcillin/k-clavulanate ≤16 ≤16
31 Tobramycin ≤4 ≤4
32 Trimethoprim/sulfamethoxazole ≤2/38 ≤2/38
Table 2: Minimum inhibitory concentration (MIC) of tested antimicrobials against 
Enterobacter aerogenes.
MIC values are presented in μg/mL; ESBL: Suspected extended-spectrum 
β-lactamases a, b screen
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either enzymatically through acetylation of the drug or mechanically 
via active drug efflux [28]. Moreover, general resistance mechanism 
involves in Enterobacter sp. against tetracycline, fluoroquinolones and 
chloramphenicol through efflux mechanism to expel the antimicrobials 
[3]. Biofield treatment on E. aerogenes showed improved susceptibility 
of chloramphenicol, which suggested that biofield treatment might 
acetylate the chloramphenicol molecule. Improved sensitivity might 
be correlated with acetylation that may happen via active drug efflux 
mechanism as compared to control. 
A significant decreased MIC value of chloramphenicol with 
increased antimicrobial sensitivity was reported with respect to control. 
Increased incidence of nosocomial infections and broad resistance to 
third generation cephalosporins, penicillins and quinolones are a serious 
problem. However, fourth generation antimicrobials remain effective 
for treatment but with serious side effects [29]. Aminoglycosides, 
quinolones, trimethoprim/sulphamethoxazole, and carbapenems 
displayed good activity against Gram-negative pathogens including 
Enterobacter species [30]. Mr. Trivedi’s biofield treatment showed a 
significant decrease in MIC values of chloramphenicol and norfloxacin, 
which suggested an alteration at enzymatic/genetic level. Alterations 
might affect the β-lactamases production that may lead to decrease the 
MIC, which is required to inhibit the growth of E. aerogenes.  
Organism identification by biochemical reactions
The biochemical reactions of E. aerogenes are presented in Table 
3. Overall, 9.09% biochemical reactions were altered out of thirty-
three tested biochemicals. In the present study, nitrate and Voges-
Proskauer biochemicals showed negative reaction i.e. positive (+) 
to negative (-) as compared to control. However, kanamycin showed 
positive reaction i.e. negative (-) to positive (+) with compared to 
control. Rest of thirty biochemicals did not show any alteration in 
metabolic reactions with respect to control. Different phenotypic 
identification tests were available to differentiate the Enterobacter 
species. Experimental identification of E. aerogenes was performed 
using a series of biochemical reactions. Enterobacter species have 
basic characteristic reactions such as the presence of Voges-Proskauer, 
sucrose, dextrose, glucose, lactose, rhamnose, citrate, lysine, ornithine 
decarboxylase, and motile in nature. Indole, methyl red and hydrogen 
sulphide are the negative characteristic tests of Enterobacter species. 
Biochemical reactions tested in the control group were well supported 
with literature data [31,32]. Biofield treatment might involve some 
enzymatic alterations in E. aerogenes, which resulted in alterations in 
characteristic biochemical reactions. 
Organism identification by biotype number
E. aerogenes was identified based on a variety of conventional 
biochemical characters and biotyping. After interpreting the results 
of the biochemical reactions, biotype number of E. aerogenes was 
evaluated using automated Microscan system. The biotype number 
then led to the organism identification. In this experiment, biotyping 
was performed, and results found a significant change in biotype 
number (7770 5272) in treated group as compared to control (7770 
5372). Organism identified in both the groups was same as E. aerogenes. 
Our research group recently reported the significant alterations in 
biochemical reactions followed by the change in biotype number that 
also supported with published data [18-20]. 
Random Amplified Polymorphic DNA (RAPD) analysis
Treated and control samples were identified on the basis of their 
different and discriminative RAPD patterns. RAPD is a new tool that is 
being used now a days to correlate the genetic similarity or mutations 
between species. The simplicity and wide applicability of RAPD 
analysis mainly depend on the use of short nucleotide primers, which 
were unrelated to known DNA sequences of the target organism [33]. 
DNA polymorphism can be efficiently detected using PCR primers 
and identify interstrain variations among species in treated samples 
[34]. The degree of relatedness and genetic mapping can be correlated 
between similar or different treated sample species [35]. 
Random amplified polymorphic-DNA fragment patterns of E. 
aerogenes control, and treated samples were generated using five 
RAPD primers and shown in Figure 1, with 100 base pair (bp) of 
DNA ladder. The polymorphic bands in control and treated samples 
are marked by arrows. The RAPD patterns of treated samples showed 
some unique and dissimilar bands among control and treated samples. 
DNA polymorphism analyzed by RAPD analysis, total number of 
bands, common, and unique bands were summarized in Table 4. The 
level of polymorphism between control and treated samples (A, A1, B, 
and B1) are summarized in Table 5. The level of polymorphism was 
found in an average range of 4 to 42% in treated samples as compared 
S. No. Code Biochemical Control Treated
1 ACE Acetamide - -
2 ADO Adonitol + +
3 ARA Arabinose + +
4 ARG Arginine - -
5 CET Cetrimide - -
6 CF8 Cephalothin + +
7 CIT Citrate + +
8 CL4 Colistin - -
9 ESC Esculin hydrolysis + +
10 FD64 Nitrofurantoin - -
11 GLU Glucose + +
12 H2S Hydrogen sulfide - -
13 IND Indole - -
14 INO Inositol + +
15 K4 Kanamycin - +
16 LYS Lysine + +
17 MAL Malonate + +
18 MEL Melibiose + +
19 NIT Nitrate + -
20 OF/G Oxidation-Fermentation + +
21 ONPG Galactosidase + +
22 ORN Ornithine + +
23 OXI Oxidase - -
24 P4 Penicillin + +
25 RAF Raffinose + +
26 RHA Rhamnose + +
27 SOR Sorbitol + +
28 SUC Sucrose + +
29 TAR Tartrate + +
30 TDA Tryptophan Deaminase - -
31 TO4 Tobramycin - -
32 URE Urea - -
33 VP Voges-Proskauer + -
-: negative; +: positive  
Table 3: Effect of biofield treatment on multidrug resistant lab isolates of 
Enterobacter aerogenes to the vital processes occurring in living organisms.
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Lane 1 to 5 represents as 1: control, 2: treated A, 3: treated A-1, 4: treated B, 5: treated B-1; M: 100 bp DNA 
Ladder; Polymorphic DNA bands are marked by arrows 
 
Figure 1 Random amplified polymorphic-DNA fragment patterns of Enterobacter aerogenes generated using 
five RAPD primers, RBA 8A, RBA 13A, RBA 20A, RBA 10A and RBA 15A. 
S. No. Primer Nucleotide sequence (5ˊ-3ˊ) Bands scored
Common bands in 
control and treated
Unique band
Control TSA TSA-1 TSB TSB-1
1 RBA 8A GTTTCGCTCC 15 7 - 1 - - -
2 RBA 13A GTGGATCCGA 14 10 - 2 - - -
3 RBA 20A GCGATCCCCA 12 7 - 1 - 1 1
4 RBA 10A CCGCAGCCAA 13 1 - - - - -
5 RBA 15A AAGAGCCCGT 11 8 - 1 - - -
TSA: treated sample A; TSA-1: treated sample A-1; TSB: treated sample B; TSB-1: treated sample B-1.
Table 4: DNA polymorphism analyzed by random amplified polymorphic DNA (RAPD) analysis.
Primer C and TSA C and TSA-1 C and TSB C and TSB-1 TSA and TSA-1 TSB and TSB-1 TSA and TSB TSA-1 and TSB-1
RBA 8A 33% 0% 0% 0% 25% 0% 33% 0%
RBA 13A 30% 0% 10% 0% 30% 9% 20% 0%
RBA 20A 41% 0% 50% 0% 45% 45% 11% 0%
RBA 10A 70% 30% 70% 0% 40% 44% 0% 30%
RBA 15A 40% 20% 20% 20% 18% 0% 20% 0%
Average polymorphism 42% 10% 30% 4% 31% 19% 16% 6%
C: control; TSA: treated sample A; TSA-1: treated sample A-1; TSB: treated sample B; TSB-1: treated sample B-1
Table 5: Level of polymorphism between control and treated samples after biofield treatment.
to control, while 6 to 31% among treated samples of E. aerogenes after 
the biofield treatment. The highest change (70%) in DNA sequence was 
observed in treated groups with RBA 10A primer as compared to the 
control; however no change was found in treated group (control and 
A1,B, and B1; B and B1, A1 and B1) with RBA 8A primer as compared 
to the control. Likewise, RBA13A and RBA20A also showed no 
polymorphism between control and treated samples of E. aerogenes after 
the biofield treatment (Table 5). In the present exploration, difference 
of polymorphic bands DNA were visualized and scored accordingly. 
Most of the polymorphic bands shown in the gel image were more than 
500 bp, while some bands were reported to have around 150 and 250 
bp. The primer RBA10A, showed three and four polymorphic bands 
(marked by arrow) in control and treated (A and B), while RBA20A 
showed five polymorphic bands in treated samples (A and B) only.
16S rDNA genotyping
Molecular PCR assay based on 16S rDNA amplification protocol 
using standard forward and reverse 16S universal primers have been 
commonly used as a taxonomic “gold standard” in identification and 
determining the phylogenies of bacterial species [36]. 16S rDNA 
sequencing was performed in biofield treated E. aerogenes to identify 
the other closely related species of treated sample. The alignment and 
comparison of the gene sequences were performed with the sequences 
stored in Gen Bank database available from NCBI using the algorithm 
BLASTn program. Based on nucleotides homology and phylogenetic 
analysis the Microbe (Sample 8A) was closely detected as genus-species 
to Kluyvera cryocrescens (GenBank Accession Number: AM184245) 
with 97% identity, which was nearest homolog genus-species to 
Enterobacter aerogenes (Accession No. AB244467). The closest 
sequences of E. aerogenes obtained from sequence alignment using 
NCBI GenBank and ribosomal database project (RDP) was presented 
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in Table 6. Distance matrix based on nucleotide sequence homology 
(Using Kimura-2 Parameter) indicates nucleotide similarity and distance 
identities between sample ‘8A’ and other ten closest homologs microbe 
of E. aerogenes was calculated and shown in Table 7. Phylogenetic tree 
of the partial 16S rDNA gene sequencing using MEGA 3.1 software by 
neighbor joining method are presented in Figure 2, ten closely related 
bacterial species as Operational Taxonomic Units (OTUs) in order to 
investigate the phylogenetic relationship of E. aerogenes among other 
ten other bacterial species. There were 1486 base nucleotides of 16S 
rDNA gene sequences were analyzed and multiple alignment were 
constructed using ClustalW in MEGA 3.1 software [25]. According to 
the data in Table 7, the lowest value of the genetic distance from E. 
aerogenes was 0.031 base substitutions per site. All pairwise distance 
analysis was carried out using the p-distance method in MEGA 3.1. The 
proportion of remarked distance, sometimes also called p-distance and 
showed as the number of nucleotide distances site. Values in Table 7 
were programmed into Figure 2 with optimal bootstrap consensus tree. 
Alignment View ID Alignment results Sequence description
8A 0.87 Sample studied
AB244467 0.99 Enterobacter aerogenes strain: C1111
AB244456 0.98 Enterobacter aerogenes strain: An19-2
AB244445 0.98 Enterobacter aerogenes strain: An10-1
AJ251468 0.98 Enterobacter aerogenes strain NCTC10006T
AB244472 0.97 Enterobacter aerogenes strain: NC4211
AB244302 0.97 Enterobacter aerogenes strain: A13-1
EU304255 0.98 Pantoea agglomerans
Y17666 0.98 Klebsiella ornithinolytica strain FSK9555
Y17670 0.99 Klebsiella terrigena strain SW4
AM184245 0.97 Kluyvera cryocrescens strain WAB1904
Table 6: The closest sequences of Enterobacter aerogenes from sequence alignment using NCBI GenBank and ribosomal database project (RDP).
Distance Matrix
AN 1 2 3 4 5 6 7 8 9 10 11
AB244445 1 — 0.999 1 0.987 1 0.992 1 0.988 0.992 0.999 0.972
AB244302 2 0.001 — 0.999 0.987 0.999 0.992 0.999 0.987 0.992 1 0.971
AB244456 3 0.000 0.001 — 0.987 1 0.992 1 0.988 0.992 0.999 0.972
EU304255 4 0.013 0.013 0.013 — 0.987 0.989 0.987 0.999 0.987 0.987 0.965
AJ251468 5 0.000 0.001 0.000 0.013 — 0.992 1 0.988 0.992 0.999 0.972
Y17666 6 0.008 0.009 0.008 0.011 0.008 — 0.992 0.990 0.990 0.992 0.971
AB244467 7 0.000 0.001 0.000 0.013 0.000 0.008 — 0.988 0.992 0.999 0.972
Y17670 8 0.012 0.013 0.012 0.001 0.012 0.010 0.012 — 0.987 0.987 0.966
AM184245 9 0.008 0.009 0.008 0.013 0.008 0.010 0.008 0.013 — 0.992 0.969
AB244472 10 0.001 0.000 0.001 0.013 0.001 0.009 0.001 0.013 0.009 — 0.971
8A 11 0.028 0.029 0.028 0.035 0.028 0.029 0.028 0.034 0.031 0.029 —
AN: Accession number
Table 7: Distance matrix based on nucleotide sequence homology (Using Kimura-2 Parameter) indicates nucleotide similarity (above diagonal) and distance (below 
diagonal) identities between the studied sample ‘8A’ and ten closest homologs microbe.
 
 
Figure 2 Phylogenetic tree of the partial 16S rDNA gene sequencing using MEGA 3.1 software by Neighbor joining method. Numbers represent GenBank accession number
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In the phylogram, there were eleven OTUs. Based on the phylogenetic 
tree and 16S rDNA sequencing, the nearest homolog genus-species was 
found to be E. aerogenes.
Conclusion 
Based on these results, it can be concluded that biofield treatment 
has the significant impact in altering the sensitivity of antimicrobials 
against E. aerogenes. Mr. Trivedi’s biofield energy treatment on E. 
aerogenes showed improved the sensitivity of resistant chloramphenicol, 
while decreased MIC value by two folds, in case of chloramphenicol and 
norfloxacin against E. aerogenes as compared to control. Biochemical 
reactions were also altered followed by change in biotype number after 
biofield treatment. Using RAPD markers, the sample was characterized 
and showed 4 to 42% interspecific polymorphic relationship with E. 
aerogenes after biofield treatment. Molecular method using 16S rDNA 
analysis showed that sample detected as Kluyvera cryocrescens with 97% 
identity, which was nearest homolog species to Enterobacter aerogenes. 
Overall, it seems that Mr. Trivedi’s unique biofield treatment might 
be used as an alternate treatment approach in future than the existing 
antimicrobial therapy. 
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